Showing 15 posts of 16 posts found.

Oxford University to collaborate with Oracle on COVID variant research

May 17, 2021
Sales and Marketing AI, COVID-19, Oxford, variants

In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …


Rising to the challenge of delivering therapeutic discovery for mental disorders

November 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health

Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …


UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres

November 6, 2018
Manufacturing and Production, Research and Development AI, Leeds, London, Oxford, UK, glasgow, pharma

The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced …


New AI system for lung cancer and heart disease could save NHS billions

January 4, 2018
Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma

A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …

Google image

Google backs Oxford Sciences Innovation

June 22, 2015
Medical Communications, Sales and Marketing Oxford, Oxford Sciences Innovation, google, ventures

Google has invested into a company that funds spinoffs from Oxford University’s technology and science departments called Oxford Sciences Innovation …

Vaccine image

New malaria vaccine found effective in adults

May 8, 2015
Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria

A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …

MedImmune image

AstraZeneca signs immuno-oncology deal with UK firm

April 16, 2015
Research and Development, Sales and Marketing AstraZeneca, IMCgp100, MEDI4736, MedImmune, Oxford, immuno-oncology, immunocore, melanoma, tremelimumab

UK pharma and biotech firms AstraZeneca and Immunocore are teaming up to launch early-stage studies of potential new cancer treatments. …

Alzheimer’s Research UK image

£30m drug discovery centres launched to overcome pharma ‘funding fatigue’

February 18, 2015
Research and Development, Sales and Marketing Alzheimer’s Research UK, Cambridge, London, Oxford, dementia, funding, pharma

Three new drug discovery institutes will be launched in the UK with a £30 million commitment to fast-track the development …

Pills image

Hormone replacement therapy elevates ovarian cancer risk

February 13, 2015
Research and Development, Sales and Marketing Cancer, HRT, Lancet, Oxford, oncology, ovarian

According to a new study women who undergo hormone replacement therapy nearly double their risk of developing ovarian cancer.  Findings …

Asthma image

Laser testing could lead to improved asthma therapies

November 13, 2014
Research and Development, Sales and Marketing Oxford, asthma, pmdis, pope, stfc

UK scientists have used a laser beam trap to examine how drug particles from asthma inhalers travel through the air …

Lilly image

Lilly signs Immunocore deal

July 17, 2014
Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly

Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …

Bayer in Oxford tie-up

July 11, 2014
Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university

Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …

Aerial view of Milton Park image

UK invests in Oxford bioscience site

January 31, 2014
Research and Development, Sales and Marketing Milton Park, Oxford, UK, bioscience, government

The government is putting £7 million into Milton Park, near Oxford, to boost the building of a new laboratory and …

Billions spent on European cancer care

October 15, 2013
Research and Development, Sales and Marketing Cancer, Europe, Lancet, Oxford, Pfizer

A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …

Latest content